β‐catenin as a potential key target for tumor suppression Y Fu, S Zheng, N An, T Athanasopoulos, L Popplewell, A Liang, K Li, ... International journal of cancer 129 (7), 1541-1551, 2011 | 101 | 2011 |
Glioma derived isocitrate dehydrogenase-2 mutations induced up-regulation of HIF-1α and β-catenin signaling: Possible impact on glioma cell metastasis and chemo-resistance Y Fu, S Zheng, Y Zheng, R Huang, N An, A Liang, C Hu The international journal of biochemistry & cell biology 44 (5), 770-775, 2012 | 60 | 2012 |
Cancer stem cell hypothesis: a brief summary and two proposals S Zheng, L Xin, A Liang, Y Fu Cytotechnology 65, 505-512, 2013 | 49 | 2013 |
A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study YJ Fu, N An, KG Chan, YB Wu, SH Zheng, AH Liang Biotechnology letters 33, 1309-1317, 2011 | 41 | 2011 |
BmK CT-conjugated fluorescence nanodiamond as potential glioma-targeted imaging and drug Y Fu, N An, S Zheng, A Liang, Y Li Diamond and related materials 21, 73-76, 2012 | 35 | 2012 |
Molecular mechanism of anti-cancer activity of the nano-drug C-PC/CMC-CD59sp NPs in cervical cancer L Jiang, Y Wang, F Zhu, G Liu, H Liu, H Ji, S Zheng, B Li Journal of Cancer 10 (1), 92, 2019 | 25 | 2019 |
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme S Zheng, W Tao Cancers 12 (9), 2368, 2020 | 23 | 2020 |
The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia GM Leclerc, S Zheng, GJ Leclerc, J DeSalvo, RT Swords, JC Barredo Leukemia research 50, 1-10, 2016 | 21 | 2016 |
A potential strategy for high-grade gliomas: combination treatment with lithium chloride and BmK CT Y Fu, S Zheng, R Huang, N An, Y Zheng, Z Zhang, A Liang Biotechnology letters 34, 9-17, 2012 | 21 | 2012 |
Classification and identification of bacteria in the soil treated by AcMNPV using high-throughput sequencing technique Y Fu, X Li, S Zheng, J Du, A Liang Biotechnology and Bioprocess Engineering 20, 931-936, 2015 | 18 | 2015 |
Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9 Y Fu, Y Zheng, K Li, R Huang, S Zheng, N An, A Liang Biotechnology letters 34, 441-446, 2012 | 18 | 2012 |
Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia S Zheng, GM Leclerc, B Li, RT Swords, JC Barredo Oncotarget 9 (5), 5529, 2018 | 17 | 2018 |
Combination of lithium chloride and pEGFP-N1-BmK CT effectively decreases proliferation and migration of C6 glioma cells Y Fu, Y Jiao, S Zheng, A Liang, F Hu Cytotechnology 68, 197-202, 2016 | 15 | 2016 |
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling S Zheng, Y Wu, Z Li Radiotherapy and Oncology 154, 36-44, 2021 | 12 | 2021 |
Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme S Zheng, Z Li Aging 12 (17), 17380-17392, 2020 | 11 | 2020 |
Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs S Zheng, W Tao Frontiers in Oncology 10, 1517, 2020 | 9 | 2020 |
Age-related copy number variations and expression levels of F-box protein FBXL20 predict ovarian cancer prognosis S Zheng, Y Fu Translational Oncology 13 (12), 100863, 2020 | 8 | 2020 |
Klebsiella pneumoniae invasive syndrome in a diabetic patient with gallbladder abscess S Zheng, S Florescu, M Mendoza Clinical Case Reports, 2020 | 8 | 2020 |
Regulation analysis of AcMNPV-mediated expression of a Chinese scorpion neurotoxin under the IE1, P10 and PH promoter in vivo and its use as a potential bio-insecticide Y Fu, X Li, J Du, S Zheng, A Liang Biotechnology letters 37, 1929-1936, 2015 | 7 | 2015 |
A functional artificial neural network for noninvasive pretreatment evaluation of glioblastoma patients E Zander, A Ardeleanu, R Singleton, B Bede, Y Wu, S Zheng Neuro-Oncology Advances 4 (1), vdab167, 2022 | 5 | 2022 |